Atlas One · Host Biology · Scale 07 — System

Venous Thromboembolism

Venous thromboembolism (VTE; DVT + PE) affects ~1-2 per 1,000 adults/year; Virchow's triad (stasis, hypercoagulability, endothelial injury) drives pathogenesis. DOACs (apixaban, rivaroxaban) are first-line; catheter-directed thrombolysis and ECMO for massive PE.

Also known as: VTE, venous thromboembolism, DVT, deep vein thrombosis, PE, pulmonary embolism, deep venous thrombosis, thrombosis venous, venous clot

Scale 07 — SystemScale
draftStatus
2026-06-07Last Reviewed
This is an auto-generated stub page built from atlas entry frontmatter. A richer hand-crafted page is planned. See the atlas source for the full entry including detailed body sections.
venous-thromboembolism

Venous Thromboembolism

Venous thromboembolism (VTE; DVT + PE) affects ~1-2 per 1,000 adults/year; Virchow's triad (stasis, hypercoagulability, endothelial injury) drives pathogenesis. DOACs (apixaban, rivaroxaban) are first-line; catheter-directed thrombolysis and ECMO for massive PE.

Entry Metadata

FieldValue
IDvenous-thromboembolism
NameVenous Thromboembolism
Statusdraft
Last reviewed2026-06-07
Atlas01-human
Scale07-system

Cross-Atlas Connections

connects-toThrombin connects-toAntiphospholipid Syndrome connects-toVon Willebrand Factor connects-toProtein C connects-toInherited Thrombophilia connects-toHeparin Induced Thrombocytopenia connects-toAntithrombin connects-toHemophilia A treated-byWarfarin

Sources